Pfizer has agreed to pay $44 million to settle allegations involving its smoking-cessation drug, Chantix. While specifics remain limited, individuals who have used Chantix may wish to follow developments to determine if they qualify for a portion of the settlement.

A recent letter to the editor stresses that there has never been a better time to quit smoking. By connecting smoking to various health concerns—from cancer to chronic diseases—the piece highlights the broad benefits of ceasing tobacco use.